Follow
Luigi Pasini
Luigi Pasini
IRST - Scientific Institute of Romagna for the Study and Treatment of Cancer
Verified email at luigipasini.com
Title
Cited by
Cited by
Year
AURA 2: Empowering discovery of post-transcriptional networks
E Dassi, A Re, S Leo, T Tebaldi, L Pasini, D Peroni, A Quattrone
Translation 2 (1), e27738, 2014
852014
Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation
L Amazit, L Pasini, AT Szafran, V Berno, RC Wu, M Mielke, ED Jones, ...
Molecular and cellular biology, 2007
832007
Prognostic role of circulating miRNAs in early-stage non-small cell lung cancer
P Ulivi, E Petracci, G Marisi, S Baglivo, R Chiari, M Billi, M Canale, ...
Journal of clinical medicine 8 (2), 131, 2019
552019
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood
M Notarangelo, C Zucal, A Modelska, I Pesce, G Scarduelli, C Potrich, ...
EBioMedicine 43, 114-126, 2019
502019
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
M Canale, K Andrikou, I Priano, P Cravero, L Pasini, M Urbini, A Delmonte, ...
Cancers 14 (5), 1143, 2022
452022
Liquid biopsy for the detection of resistance mechanisms in NSCLC: comparison of different blood biomarkers
L Pasini, P Ulivi
Journal of clinical medicine 8 (7), 998, 2019
412019
A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy
V Sidarovich, M De Mariano, S Aveic, M Pancher, V Adami, P Gatto, ...
Molecular cancer therapeutics 17 (7), 1405-1415, 2018
352018
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer
M Canale, L Pasini, G Bronte, A Delmonte, P Cravero, L Crinò, P Ulivi
Translational Lung Cancer Research 8 (Suppl 3), S265, 2019
272019
TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines
L Pasini, A Re, T Tebaldi, G Ricci, S Boi, V Adami, M Barbareschi, ...
BMC cancer 15, 1-18, 2015
262015
Extracellular vesicles in non-small-cell lung cancer: functional role and involvement in resistance to targeted treatment and immunotherapy
L Pasini, P Ulivi
Cancers 12 (1), 40, 2019
232019
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp …
A Siggillino, P Ulivi, L Pasini, MS Reda, E Chiadini, FR Tofanetti, ...
Diagnostics 10 (12), 1062, 2020
142020
Melanoma: targeting signaling pathways and RaLP
L Pasini, MY Turco, L Luzi, E Aladowicz, E Fagiani, L Lanfrancone
Expert Opinion on Therapeutic Targets 13 (1), 93-104, 2009
142009
Unveiling mutational dynamics in non‐small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA
L Pasini, M Notarangelo, A Vagheggini, MA Burgio, L Crino, E Chiadini, ...
Molecular Oncology 15 (9), 2423-2438, 2021
102021
Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients
S Boi, T Tebaldi, A Re, C Cantaloni, V Adami, M Barbareschi, ...
Genes, Chromosomes and Cancer 53 (6), 487-496, 2014
72014
Instability of non-standard microsatellites in relation to prognosis in metastatic colorectal cancer patients
F Pirini, L Pasini, G Tedaldi, E Scarpi, G Marisi, C Molinari, D Calistri, ...
International Journal of Molecular Sciences 21 (10), 3532, 2020
62020
Comparative analysis of free-circulating and vesicle-associated plasma microRNAs of healthy controls and early-stage lung cancer patients
L Pasini, I Vannini, P Ulivi, M Tebaldi, E Petracci, F Fabbri, F Stella, ...
Pharmaceutics 14 (10), 2029, 2022
22022
SHC4 (SHC (Src homology 2 domain containing) family, member 4)
L Pasini, L Lanfrancone
Atlas Genet Cytogenet Oncol Haematol 14 (8), 732-734, 2011
22011
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer
A Verlicchi, M Canale, E Chiadini, P Cravero, M Urbini, K Andrikou, ...
Life 13 (9), 1915, 2023
12023
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
P Ulivi, A Passardi, G Marisi, E Chiadini, C Molinari, M Canale, L Pasini, ...
Frontiers in pharmacology 12, 745701, 2021
12021
Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: Safety and efficacy
G Bronte, A Cafaro, L Pasini, I Priano, K Andrikou, P Cravero, MA Burgio, ...
Expert Review of Anticancer Therapy 21 (8), 809-817, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20